IndiaOne Finance - Company Dashboard

Governance Classic Home

Anlon Healthcare LtdPharmaceuticalsINE0Y8W01025

Valuation

Market Cap₹1.22K Cr

TTM PE3.97x

Forward PE9.41x

PEG2.51

Book Value₹39.48

P/B0.58x

TTM EPS₹5.77

Fwd EPS₹2.43

TTM Revenue₹150.75 Cr

TTM PAT₹24.57 Cr

TTM EBITDA₹47.52 Cr

TTM EBIT₹46.00 Cr

Last Qtr PAT₹11.07 Cr

Last Qtr EBITDA₹47.52 Cr

Last Qtr EBIT₹46.00 Cr

Profitability

ROE—

ROCE—

TTM NPM16.30%

TTM EBITDA %31.52%

Curr OPM15.46%

Last OPM21.75%

Curr NPM—

Last NPM—

Curr EPS₹0.09

Last EPS₹1.17

Balance sheet

Equity—

Reserve—

Total Debt₹0.00 Cr

D/E—

Interest %20.00%

Curr Interest₹0.96 Cr

Price / range

Close₹22.90

vs 52W High-7.59%

vs 52W Low+90.83%

MA50—

MA200—

Returns

1D+4.85%

1W+17.52%

1M+57.12%

3M+45.19%

6M+100.70%

1Y+72.74%

2Y—

3Y—

5Y—

Diwali-22.61%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	171.97
Other Income	0.26
Total Income	172.22
Expenditure	-129.71
Interest	-3.74
PBDT	0
EBITDA	47.52
Depreciation	-1.52
EBIT	46
PBT	42.51
Tax	-13.42
Equity	53.15
OPM (%)	24.68
Net Profit	29.09
NPM (%)	16.89
EPS (Rs)	6.11
CEPS	6.11

Metric	Jun-26	Mar-26	FY25-26
Revenue	87.56	50.89	171.97
Other Income	0.06	0.01	0.26
Total Income	87.62	50.90	172.22
Interest	0.92	0.57	3.74
Expenditure	-73.96	-36.46	-129.71
PBDT	0	0	0
EBITDA	15.59	15.29	47.52
Depreciation	-1.07	-0.29	-1.52
EBIT	14.52	15	46
PBT	13.66	14.44	42.51
Tax	-5.38	-3.37	-13.42
Equity	106.30	53.15	53.15
OPM	15.59	28.37	24.68
Net Profit	8.28	11.07	29.09
NPM	9.45	21.75	16.89
EPS	0.16	2.33	6.11

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	171.97
Other Income	0.26
Total Income	172.22
Expenditure	-129.71
Interest	-3.74
PBDT	0
EBITDA	47.52
Depreciation	-1.52
EBIT	46
PBT	42.51
Tax	-13.42
Equity	53.15
OPM (%)	24.68
Net Profit	29.09
NPM (%)	16.89
EPS (Rs)	6.11
CEPS	6.11

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

Year	Ratio	Ex-Date
2026	1:1	24 Apr 2026

Split

Year	Ratio	Ex-Date
2026	Rs.10/- to Rs.2/-	24 Apr 2026

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split